Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Chemoradiation for Distal Rectal Cancer
NCT00006366Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Feb 2001
- Primary completion
- Dec 2003
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of irinotecan in rectal cancer, sponsored by NRG Oncology. Started Feb 2001; status: completed.
02
Drugs
irinotecan
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00006366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006366.